Mitsutoshi Uchida

Partner | Tokyo
|
81 3 3214 6522

Video + Audio

Experience

Represented Astellas Pharma in its sale of 16 off-patent brand-name drugs for approximately $180 million (¥20.1 billion) to LTL Pharma Co., Ltd., a company founded by investment fund Unison Capital.

Represented Aetos Capital Real Estate in its sale of Simplex Investment Advisors, a Japanese real estate asset management firm, to Hulic Co., Ltd. for approximately $1.3 billion.

Represented Sekisui House Residential Investment in its approximately $2.3 billion merger with Sekisui House Reit, Inc., both public J-REITs sponsored by Sekisui House Ltd.

Represented CPG, a Thailand-based diversified conglomerate in Asia, in its $1.8 billion cross-investment and strategic alliance with ITOCHU Corporation.

Represented NEXON in its ¥98 billion global IPO, serving as issuer’s counsel.

Represented Kenedix Retail REIT in its ¥72 billion global IPO and follow-on global equity offerings, serving as underwriters’ counsel.

Represented Japan Retail Fund Investment in multiple follow-on global equity offerings, serving as underwriters’ counsel.

Represented Olympus in its ¥118 billion global equity offering, serving as underwriters’ counsel.

Represented Shinsei Bank in its ¥75 billion global equity offering, serving as underwriters’ counsel.


Chambers Asia-Pacific 2022

Ranked in Japan: Capital Markets: Domestic (J-REITs)